Dehlin M, Jacobsson L, Roddy E (2020) Global epidemiology of gout: prevalence, incidence, treatm ent patterns and risk factors. Nat Rev Rheumatol 16:380–390. https://doi.org/10.1038/s41584-020-0441-1

Article  PubMed  Google Scholar 

Dalbeth N, Merriman TR, Stamp LK (2016) Gout. Lancet 388:2039–2052. https://doi.org/10.1016/S0140-6736(16)00346-9

Article  CAS  PubMed  Google Scholar 

Dalbeth N, Gosling AL, Gaffo A, Abhishek A (2021) Gout. Lancet 397:1843–1855. https://doi.org/10.1016/S0140-6736(21)00569-9

Article  CAS  PubMed  Google Scholar 

Lin J, Zhao GQ, Che CY, Yang SS, Wang Q, Li CG (2013) Characteristics of ocular abnormalities in gout patients. Int J Ophthalmol 6:307–311. https://doi.org/10.3980/j.issn.2222-3959.2013.03.09

Article  PubMed  PubMed Central  Google Scholar 

Morris WR, Fleming JC (2003) Gouty tophus at the lateral canthus. Arch Ophthalmol 121:1195–1197. https://doi.org/10.1001/archopht.121.8.1195

Article  PubMed  Google Scholar 

Lo WR, Broocker G, Grossniklaus HE (2005) Histopathologic examination of conjunctival tophi in gouty arthritis. Am J Ophthalmol 140:1152–1154. https://doi.org/10.1016/j.ajo.2005.07.023

Article  PubMed  Google Scholar 

Coassin M, Piovanetti O, Stark WJ, Green WR (2006) Urate deposition in the iris and anterior chamber. Ophthalmology 113:462–465. https://doi.org/10.1016/j.ophtha.2005.11.012

Article  PubMed  Google Scholar 

Yazdanyar A, Rizzuti AE, Mechel E, Denisova K, Lazzaro DR (2018) Gout keratitis: a case of peripheral ulcerative keratitis secondary to gout with a review of the literature. Cornea 37:379–381. https://doi.org/10.1097/ICO.0000000000001415

Article  PubMed  Google Scholar 

Ferry AP, Safir A, Melikian HE (1985) Ocular abnormalities in patients with gout. Ann Ophthalmol 17:632–635

CAS  PubMed  Google Scholar 

Luo C, Chen X, Jin H, Yao K (2017) The association between gout and cataract risk: a meta-analysis. PLoS ONE 12:e180188. https://doi.org/10.1371/journal.pone.0180188

Article  CAS  Google Scholar 

Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, Liu Z, Nelson JD, Nichols JJ, Tsubota K, Stapleton F (2017) TFOS DEWS II definition and classification report. Ocular Surface 15:276–283. https://doi.org/10.1016/j.jtos.2017.05.008

Article  PubMed  Google Scholar 

Chia EM, Mitchell P, Rochtchina E, Lee AJ, Maroun R, Wang JJ (2003) Prevalence and associations of dry eye syndrome in an older population: the blue mountains eye study. Clin Exp Ophthalmol 31:229–232. https://doi.org/10.1046/j.1442-9071.2003.00634.x

Article  PubMed  Google Scholar 

Moss SE, Klein R, Klein BE (2000) Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 118:1264–1268. https://doi.org/10.1001/archopht.118.9.1264

Article  CAS  PubMed  Google Scholar 

Moss SE, Klein R, Klein BE (2004) Incidence of dry eye in an older population. Arch Ophthalmol 122:369–373. https://doi.org/10.1001/archopht.122.3.369

Article  PubMed  Google Scholar 

Moss SE, Klein R, Klein BE (2008) Long-term incidence of dry eye in an older population. Optom Vis Sci 85:668–674. https://doi.org/10.1097/OPX.0b013e318181a947

Article  PubMed  Google Scholar 

Alshamrani AA, Almousa AS, Almulhim AA, Alafaleq AA, Alosaimi MB, Alqahtani AM, Almulhem AM, Alshamrani MA, Alhallafi AH, Alqahtani IZ, Alshehri AA (2017) Prevalence and risk factors of dry eye symptoms in a saudi arabian population. Mid East Afr J Ophthalmol 24:67–73. https://doi.org/10.4103/meajo.MEAJO_281_16

Article  Google Scholar 

Lee CY, Chen HC, Sun CC, Lin HY, Lu KH, Huang JY, Yeh CB, Yang SF (2019) Gout as a risk factor for dry eye disease: a population-based cohort study. J Clin Med. https://doi.org/10.3390/jcm8010062

Article  PubMed  PubMed Central  Google Scholar 

Belviranli S, Turk HB, Oltulu P, Turk N, Mirza E, Küçük A, Aydemir H, Oltulu R (2021) Tear function alterations and conjunctival impression cytology findings in patients with gout. Eye Cont Lens-Sci Clin Pract 47:647–650. https://doi.org/10.1097/ICL.0000000000000832

Article  Google Scholar 

Qian L, Wei W (2022) Identified risk factors for dry eye syndrome: a systematic review and meta-analysis. PLoS ONE 17:e271267. https://doi.org/10.1371/journal.pone.0271267

Article  CAS  Google Scholar 

Lee CY, Lian IB, Jhan YN, Yang SF, Chang CK (2022) Lifestyle and symptom risk factors for dry eye disease in Asian gout population: a population-based case-control study. J Clin Med. https://doi.org/10.3390/jcm11247378

Article  PubMed  PubMed Central  Google Scholar 

Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda J, Coyfish M, Guillo S, Jansen T, Janssens H, Liote F, Mallen CD, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell A, So AK, Tausche A, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T (2020) 2018 updated European league against rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis 79:31–38. https://doi.org/10.1136/annrheumdis-2019-215315

Article  PubMed  Google Scholar 

Di Giovine FS, Malawista SE, Nuki G, Duff GW (1987) Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol 138:3213–3218

Article  PubMed  Google Scholar 

Ragab G, Elshahaly M, Bardin T (2017) Gout: an old disease in new perspective: a review. J Adv Res 8:495–511. https://doi.org/10.1016/j.jare.2017.04.008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zha X, Yang B, Xia G, Wang S (2022) Combination of uric acid and pro-inflammatory cytokines in discriminating patients with gout from healthy controls. J Inflamm Res 15:1413–1420. https://doi.org/10.2147/JIR.S357159

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241. https://doi.org/10.1038/nature04516

Article  ADS  CAS  PubMed  Google Scholar 

Szekanecz Z, Szamosi S, Kovács GE, Kocsis E, Benkő S (2019) The NLRP3 inflammasome: interleukin 1 pathway as a therapeutic target in gout. Arch Biochem Biophys 670:82–93. https://doi.org/10.1016/j.abb.2019.01.031

Article  CAS  PubMed  Google Scholar 

Wang Z, Zhang S, Xiao Y, Zhang W, Wu S, Qin T, Yue Y, Qian W, Li L (2020) NLRP3 inflammasome and inflammatory diseases. Oxid Med Cell Longev 2020:4063562. https://doi.org/10.1155/2020/4063562

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Y, Zhao M, Pu Z, Xu G, Li X (2018) Relationship between oxidative stress and inflammation in hyperuricemia: analysis based on asymptomatic young patients with primary hyperuricemia. Medicine 97:e13108

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu Y, Wu Y, Zhou X, Inomata T, Gu L, Jin X, Hong J (2022) Editorial: advances in the pathophysiology, diagnosis, and treatment of dry eye disease. Front Med. https://doi.org/10.3389/fmed.2022.925876

Article  PubMed  PubMed Central  Google Scholar 

Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC (2001) Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci 42:2283–2292

CAS  PubMed  Google Scholar 

Yoon KC, Jeong IY, Park YG, Yang SY (2007) Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea 26:431–437. https://doi.org/10.1097/ICO.0b013e31803dcda2

Article  PubMed  Google Scholar 

Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D (1999) Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren’s syndrome keratoconjunctivitis sicca. Curr Eye Res 19:201–211. https://doi.org/10.1076/ceyr.19.3.201.5309

Article  CAS  PubMed  Google Scholar 

Ling J, Chan BC, Tsang MS, Gao X, Leung PC, Lam CW, Hu J, Wong CK (2022) Current advances in mechanisms and treatment of dry eye disease: toward anti-inflammatory and immunomodulatory therapy and traditional Chinese medicine. Front Med. https://doi.org/10.3389/fmed.2021.815075

Article  PubMed  PubMed Central  Google Scholar 

Zheng Q, Ren Y, Reinach PS, She Y, Xiao B, Hua S, Qu J, Chen W (2014) Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye. Exp Eye Res 125:1–8. https://doi.org/10.1016/j.exer.2014.05.001

Article  CAS  PubMed  Google Scholar 

So A, De Smedt T, Revaz S, Tschopp J (2007) A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 9:R28. https://doi.org/10.1186/ar2143

Article  CAS  PubMed  PubMed Central